Researchers reveal how a protein interaction can increase Alzheimer’s risk
AD is the most common form of dementia, which affects over 944,000 people in the UK
Read More
Tag: neurodgenerative diseases
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
